================================================================================


                                  EXHIBIT 32.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Amexdrug Corporation (the
"Company") on Form 10-Q/A for the period ending June 30, 2009, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Jack
Amin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to the best of my knowledge and belief:

         (1)  the Report fully complies with the requirements of Section 13(a)
              or 15(d) of the Securities Exchange Act of 1934; and

         (2)  the information contained in the Report fairly presents, in all
              material respects, the financial condition and result of
              operations of the Company.



/s/ Jack Amin
- -----------------------
Jack Amin
Chief Financial Officer
September 18, 2009

         A signed original of this written statement required by Section 906, or
         other document authenticating, acknowledging, or otherwise adopting the
         signature that appears in typed form within the electronic version of
         this written statement has been provided to the Company and will be
         retained by the Company and furnished to the Securities and Exchange
         Commission or its staff upon request. The foregoing certifications are
         accompanying the Company's Form 10-Q solely pursuant to section 906 of
         the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section
         1350, chapter 63 of title 18, United States Code) and are not being
         filed as part of the Form 10-Q or as a separate disclosure document.





- --------------------------------------------------------------------------------